SkyView Investment Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,241
Closed -$850K 814
2023
Q1
$850K Buy
9,241
+575
+7% +$50.2K 0.2% 133
2022
Q4
$786K Sell
8,666
-438
-5% -$36.9K 0.24% 134
2022
Q3
$692K Buy
9,104
+1,465
+19% +$121K 0.2% 170
2022
Q2
$646K Buy
+7,639
New +$670K 0.17% 193

Other funds holding NVS

SkyView Investment Advisors's NVS Position: Q2 2023 in Review

SkyView Investment Advisors sold out of Novartis (NVS) in Q2 2023, closing a stake of 9,241 shares — an estimated $850K sold.

SkyView Investment Advisors first reported a position in NVS in Q2 2022 and held it in 4 quarters. The position peaked at $850K in Q1 2023. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • SkyView Investment Advisors reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • SkyView Investment Advisors sold 9,241 Novartis shares in Q2 2023, an estimated $850K.
  • SkyView Investment Advisors first reported a position in Novartis in Q2 2022 and held it in 4 quarters.
  • SkyView Investment Advisors's Novartis position peaked at $850K in Q1 2023.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on SkyView Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.